Founded in 2007 by Kevin Lustig, Christopher Petersen and Andrew Martin, Scientist.com has become one of the world’s leading marketplaces for outsourced research. In this online marketplace researchers can find more than 3,500+ research tools and services, connect with more than 17,500+ global research suppliers and get access to most of the later cutting-edge technologies […]
Discover how the spanish biotech GENOMICA has become a world leader in the field of molecular diagnostics and genetic identification. since its foundation in 1990 and capitalized to 100% by its parent company PharmaMar, which is currently the Spanish multinational global leader in the development and commercialization of antitumor drugs of marine origin, grows from its birth for […]
Advanced therapies based on cellular therapies, which use stem cells and biodegradable devices or prostheses for growth and application of the same, constitute a new way to treat a variety of diseases, including heart disease called ischemic. Ischaemic heart diseases, such as heart attacks and angina pectoris, are caused by the development of arteriosclerosis in […]
The biological drugs and their biosimilar drugs constitute a paradigm of pharmacological innovation by allowing to alter the course of a disease by acting on an aspect or very specific mechanism of a specific cell, organ or system. For this reason, they have managed to improve the expectations and the quality of life for patients […]
The use of the antimalarial drug artemisinin, a sesquiterpene lactone extracted from the glandular trichomes from the plant Artemisia annua, was described for the first time in the Handbook of prescriptions for emergencies, edited by the middle of the 4th century by Ge Hong, Chinese scholar who devoted a large part of his studies to the discovery of physical immortality. […]
The case of the R+D+i Artennua project, developed by the union of forces between the Catalan biotech company Sequentia Biotech and the Canary Islands Institute of Agricultural Research (ICIA), brings together all the potential to generate natural treatments that prevent the advance of the global malaria and other diseases of high prevalence as different types of cancer, multiple sclerosis, […]
In January of this year the Spanish multinational GENOMICA, a leader in molecular diagnostics and analysis of genetic identification, announced the opening of its new subsidiaries in China and Brasil, from which, in addition to the subsidiary that opened in Sweden in January 2013, allow them to operate in the main markets of the In Vitro Diagnostic of the world: Asia, […]
«In total, it is estimated that between a 0,4% and a 1,8% of the natural extracts from the organic matter (belonging to terrestrial plants and marine animals, respectively) could contain antitumoural active principles.» Cragg GM et al (1994). The first company in the history to develop and market a medicine with marine origin was […]